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Abstract 
 
Background: Appendectomy is considered the gold-standard treatment for acute appendicitis. 
Recently the need for surgery has been challenged in both adults and children. In children there is 
growing clinician, patient and parental interest in non-operative treatment of acute appendicitis 
with antibiotics as opposed to surgery. To date no multicentre randomised controlled trials that are 
appropriately powered to determine efficacy of  non-operative treatment (antibiotics) for acute 
appendicitis in children compared to surgery (appendectomy) have been performed. 
Methods: Multicentre, international, randomised controlled trial with a non-inferiority design. 
Children (age 5-16 years) with a clinical and/or radiological diagnosis of acute uncomplicated 
appendicitis will be randomised (1:1 ratio) to receive either laparoscopic appendectomy or 
treatment with intravenous (minimum 12 hours) followed by oral antibiotics (total course 10 days). 
Allocation to groups will be stratified by gender, duration of symptoms (> or< 48 hours) and centre. 
Children in both treatment groups will follow a standardised treatment pathway. Primary outcome is 
treatment failure defined as additional intervention related to appendicitis requiring general 
anesthesia within 1 year of randomization (including recurrent appendicitis) or negative 
appendectomy. Important secondary outcomes will be reported and a cost effectiveness analysis 
will be performed. The primary outcome will be analysed on a non-inferiority basis using a 20% non-
inferiority margin. Planned sample size is 978 children. 
 
Discussion: The APPY trial will be the first multicentre randomised trial comparing non-operative 
treatment with appendectomy for acute uncomplicated appendicitis in children. The results of this 
trial have the potential to revolutionise the treatment of this common gastrointestinal emergency. 
The randomised design will limit the effect of bias on outcomes seen in other studies. 
 
Trial registration: clinicaltrials.gov: NCT02687464. Registered on Jan 13th 2016 
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What is known about this subject 
1. Appendicectomy has been the mainstay of treatment of acute appendicitis for over 100 years 
2. Recently the need for surgery for uncomplicated acute appendicitis has been challenged and 
current data suggest the majority of children can be treated with a non-operative treatment 
pathway instead of surgery 
3. The comparative safety and efficacy of non-operative treatment compared to surgery have not 
yet been determined 
 
 
What this study will add 
1. This study will determine the relative efficacy of non-operative treatment compared to 
appendicectomy for children with uncomplicated acute appendicitis 
2. The randomised study design will help to eliminate bias between treatment groups that may exist 
in other study types 
3. The pragmatic trial design will help to ensure generalisability of trial results 
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Background 
Acute appendicitis is the most common surgical emergency in children 1. The lifetime risk of 
developing appendicitis is 7-8%, with a peak incidence in the teenage years. The associated financial 
burden of treating appendicitis is very large. 
 
For over 100 years, surgical removal of the appendix has been deemed necessary to effectively treat 
acute appendicitis. Appendectomy remains the cornerstone of treatment for acute appendicitis, with 
the exception of a phlegmon or appendix mass 2. However, in recent years this surgical dogma has 
been challenged and there is a growing literature to suggest that antibiotics without surgery may be an 
effective treatment for acute appendicitis in adults and more recently in children. This non-operative 
management of acute appendicitis remains controversial and unproven due to the lack of well-
designed large prospective randomised controlled trials 3. 
 
Although appendectomy is generally a simple procedure, it requires general anaesthesia and is an 
abdominal operation with inherent risks and potential complications. Complications related to surgery 
or anesthesia occur in over 10% of children within 30 days of appendectomy 4. Although a non-
operative approach may avoid these risks and reduce the complication rate, this would not be a viable 
alternative to surgery unless it is effective at curing acute appendicitis. Another important 
consideration is that some patients with a clinical and/or radiological diagnosis of acute appendicitis 
may not actually have acute appendicitis. Even with current imaging methods, 6.3% of children in 
Canada and 4.3% in the US undergoing appendectomy are subsequently found to have a normal 
appendix 5. Consequently, this could be considered to be an unnecessary operation. Surgery causes 
trauma, physiological stress and physical scarring in the child and psychological stress and distress in 
their parents. A non-operative approach might reduce these. There may be social and economic 
benefits to the child and family arising from reduced time away from normal daily activities including 
schooling and parental time off work, and there may be benefits for the healthcare system and society. 
However, there is the issue of recurrent appendicitis. Following successful non-operative treatment, 
children would be left with an appendix and be at risk of recurrent appendicitis. The benefits of 
successful non-operative treatment would only be realised if the rate of recurrent appendicitis is low. 
If a high proportion of children will develop a recurrence, then there is likely to be less benefit from 
an initial non-operative approach. 
  
The existing literature relating to the efficacy of non-operative treatment of acute appendicitis is 
predominantly from adult patients. Several trials and systematic reviews have been reported 3 6-12. In a 
2012 meta-analysis Mason et al concluded that while there were benefits to non-operative treatment 
including fewer complications, better pain control, and shorter sick leave, the combined failure and 
recurrence rates in non-operative patients made this approach less effective overall 11. However, in the 
same year Varadhan et al concluded from their meta-analysis that ‘antibiotics can be used safely as 
primary treatment in patients presenting with acute uncomplicated appendicitis’ since 63% of patients 
respond to non-operative treatment 12 
 
In children, the literature is limited (Table 1). Whilst antibiotic therapy appears successful in the 
majority of children with acute uncomplicated appendicitis, no large randomised study of acute 
appendicitis in children has yet been performed (although there have been RCTs of antibiotic 
treatment of perforated appendicitis in children 13 14). A recent systematic review and meta-analysis of 
the efficacy of non-operative treatment of acute uncomplicated appendicitis in children demonstrated 
that non-operative treatment is effective as initial treatment in 97% of cases.15 
 
In preparation for this multicentre RCT, some of our group have performed a pilot RCT at one of the 
participating centres (Karolinska Institutet, Stockholm)16. We have successfully demonstrated 
feasibility of recruitment to a RCT and demonstrated safety of non-operative treatment of children 
with acute appendicitis. Furthermore, we have generated pilot data on which our current study is now 
based. In the pilot RCT all 26 children randomised to appendectomy had histopathologically-
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confirmed acute appendicitis and recovered without significant complications. Only 2 of 24 children 
in the antibiotic group required appendectomy for histologically-proven acute appendicitis within 1 
year. Of eligible participants, the recruitment rate was 40%, the drop-out rate following treatment 
allocation was 2% (1 patient) and no patient was lost to follow-up by 1 year. 
 
Based on these observations, and in response to parents who are now asking whether their child with 
acute appendicitis really needs an operation, we will perform a large, prospective, multicentre, 
randomised controlled trial comparing appendectomy with non-operative treatment in children with 
acute appendicitis. Our principal research question is: Can children with acute uncomplicated (non-
perforated) appendicitis be treated without appendectomy? 
 
Methods/Design 
 
Trial design 
The APPY trial has been designed as a pragmatic, parallel-group, unmasked, non-inferiority, 
multicentre, international, randomized controlled trial. The protocol has been developed in accordance 
with the SPIRIT guideline 17 and the trial will be conducted and reported according to the CONSORT 
statement 18 19. The trial is registered with clinicaltrials.gov: NCT02687464. 
Participants 
Children (5-16 years of age) with suspected acute uncomplicated appendicitis will be enrolled. All 
children with suspected acute non-perforated appendicitis will be assessed by the on-call surgeon who 
will determine eligibility for the study. This will be based on a clinical and/or ultrasound or CT 
diagnosis of acute non-perforated appendicitis. The parent(s) and child will be informed of the trial 
and invited to participate. 
 
Inclusion criteria 
 children (age 5-16 years) 
 clinical and /or radiological diagnosis (ultrasound [US] and/or CT scan) of acute non-
perforated appendicitis  
 written informed parental consent in accordance with local regulations and institutional policy 
 written informed child assent in accordance with local regulations and institutional policy 
 
 
Exclusion criteria 
 suspicion of perforated appendicitis 
 presentation with an appendix mass or phlegmon (on physical examination and/or imaging) 
 non-operative management (2 or more doses of intravenous antibiotic) initiated at an outside 
institution 
 previous episode of appendicitis or appendix mass/phlegmon treated non-operatively 
 current treatment for malignancy 
 positive pregnancy test 
 diagnosis of cystic fibrosis (CF) 
 
Randomisation 
After signed informed consent, a standardised dataset will be collected from all participants at all 
participating institutions.  Patients enrolled in the study will be randomized to groups (1:1 ratio) using 
an online stratified randomization tool, allowing instant assignment to treatment group 24 hours per 
day with concealment of allocation. Allocation to groups will be stratified taking into account factors 
that may affect outcome of treatment: 1) Gender: Male; Female; 2) Duration of symptoms <48hrs; 
>48hrs; and 3) Centre. Due to the nature of the interventions blinding will not be possible, and as 
imaging is not an inclusion criterion, it is not possible to stratify by presence/absence of faecolith 
Page 6 of 14 
 
 
 
Interventions 
Patients will be allocated to non-operative antibiotic treatment or appendectomy. Figure 1 illustrates 
patient flow through the two treatment pathways during the acute admission following randomization. 
 
Non-operative treatment group: Participants allocated to non-operative treatment will be treated 
according to a treatment pathway standardised across all centres comprising intravenous fluid 
treatment, a minimum of 12 hours of intravenous antibiotics, a minimum period of 12 hours taking 
clear fluid only, and regular clinical review. This review is conducted to detect symptoms and signs of 
clinical deterioration including, but not limited to, increased fever, increased tachycardia, and 
increased pain or tenderness. An additional formal review will be performed the following day and 
children who are stable or clinically improving will continue with non-operative treatment.  
 
Children in whom non-operative treatment is successful will receive a minimum of 12 hours 
intravenous antibiotics and then be switched to oral antibiotics once they have shown clinical 
improvement. They will be discharged home once they meet a standardised set of criteria to be used 
in all centres: vital signs (including temperature) within normal limits, tolerating a light diet orally, 
adequate oral pain relief and mobile. They will receive a total course of 10 days of antibiotics 
(intravenous and oral) following randomization. 
 
Children within the non-operative treatment group will remain under the direct care of an attending 
pediatric surgeon. If a child’s clinical condition deteriorates at any time, they will undergo 
laparoscopic appendectomy, and will receive post-operative care identical to that of children in the 
appendectomy treatment group (see below), and any other care that might be dictated by sound 
clinical judgement. 
 
The diagnosis of acute appendicitis may be confirmed, or strongly suspected in an otherwise eligible 
patient at an outside institution, prior to referral to the treating/trial centre.  A widely accepted 
standard of practice made in consultation with the treating centre, is to administer a single dose of 
intravenous antibiotic in such patients prior to transfer.  These patients will be considered eligible for 
randomization provided they have not received more than a single dose of pre-transfer intravenous 
antibiotic.  A patient who has received 2 or more doses of antibiotic prior to evaluation at the 
treating/trial centre will be considered to have “commenced conservative treatment”, and would 
therefore be ineligible for randomization.  The choice of antibiotics will vary between centres and will 
be the antibiotic regimen that is current standard of care in that centre. This is due to (i) varying 
antibiotic regimes amongst participating centres at present influenced by local factors, including 
antimicrobial stewardship and drug cost 20 and (ii) a lack of evidence to support a specific antibiotic 
regimen for childhood appendicitis. Allowing each centre to maintain current antibiotic protocols will 
improve study feasibility and increase generalizability of the results. However, the duration of 
combined intravenous and oral therapy will be standardized to 10 days. 
 
Following discharge, children who receive non-operative treatment will not be offered elective 
appendectomy. They will be counselled about the risk of recurrence as part of the consent process for 
the trial using best available data including that arising from our pilot study. Recurrence of 
appendicitis within the 1 year follow-up period will be treated with appendectomy; these children will 
not be eligible for re-enrolment. 
 
Appendectomy group:  Children allocated to appendectomy will undergo laparoscopic appendectomy 
within approximately 18 hours of randomization which is the current standard of care in all centres 
participating in this study. Participants will receive intravenous antibiotics from the time of 
randomization and be treated post-operatively with intravenous antibiotics according to a defined and 
standardized treatment regime based on consensus for this trial.  Specifically, children with a 
macroscopically normal appendix or non-perforated acute appendicitis will receive no further 
antibiotics; children with perforated appendicitis will continue to receive intravenous antibiotics for a 
minimum of 3 days, and may receive additional antibiotics per local practice. The type of antibiotics 
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used in each centre will be identical to those used in the non-operative treatment group. Following 
cessation of intravenous antibiotics, criteria for discharge home will be identical to those in the non-
operative treatment group. 
 
Outcomes 
Primary outcome 
The primary outcome is treatment failure defined as: (i) additional intervention related to appendicitis 
requiring general anesthesia within 1 year of randomization (this includes the recurrence of 
appendicitis after non-operative treatment, which will be treated with appendectomy) OR (ii) negative 
appendectomy. This definition of the primary outcome will capture all important parameters in both 
treatment groups including specifically: failure of antibiotic treatment requiring appendectomy, 
significant complication (defined as requiring general anaesthesia) in either treatment group, 
recurrence of acute appendicitis (treated by appendectomy) and negative appendectomy. 
 
Secondary outcomes: Secondary outcomes are objective measures of treatment efficacy that fulfil 
important core areas of relevance to clinicians and patients (pathophysiological manifestations, life 
impact, resource use and death) 21. We have selected secondary outcomes which we believe to be 
important and relevant for future treatment decisions. They will be recorded as they illustrate clinical 
course and are objectively measurable in a large multicentre RCT: 
 
 complications: adverse events related to either non-operative treatment of appendicitis or 
appendectomy which require additional interventions without general anesthesia, during the 
first year following randomization will be categorized according to the Clavien-Dindo 
classification 22 
 time to discharge home after randomization measured in hours as a continuous variable 
 number and duration of hospital admissions related to appendicitis, appendectomy or their 
complications during the first year following randomization. 
Other secondary outcomes will be collected and compared between treatment groups. We will also 
undertake a full cost effectiveness analysis to examine the incremental cost (savings) of non-operative 
treatment versus appendectomy per treatment failure averted. 
Follow up 
All participants will be seen in the outpatient clinic at 6 weeks following discharge and again at 3 
months and 1 year following randomization for collection of secondary outcome data. Details of any 
unscheduled healthcare visits specific to the previous episode of appendicitis will be recorded 
contemporaneously if at the same institution, or will be inquired about at the 3 month and 1 year 
follow-up appointments. If families are unable to attend for follow-up then consultation by 
telemedicine facility or telephone will be undertaken. 
 
We will obtain permission from these families to hold their personal contact details in a secure 
registry and to contact them in the future to determine in a longer follow-up study if they have had 
complications that may be attributed to treatment (including recurrence of appendicitis). 
 
Sample size calculation 
The sample size has been calculated to test our null hypothesis that non-operative treatment with 
antibiotics is inferior to appendectomy. Data contributing to our calculations arise from our pilot RCT 
data 16, the existing literature in adult patients and recent (2012) outcomes data from the 14 
participating centres.  
In the appendectomy treatment group, the estimate of participants meeting criteria for the primary 
endpoint is based on the negative appendectomy rate and post-operative need for re-intervention rate, 
which were estimated from the recent experience collected from each participating center. We found a 
5% negative appendectomy rate and 2% post-appendectomy rate of intervention requiring general 
anaesthesia. The anticipated proportion of participants with treatment failure in the appendectomy 
group is therefore 7%. 
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In the non-operative treatment group the estimate of participants meeting criteria for the primary 
endpoint is based on a 20% incidence of additional intervention requiring general anesthesia related to 
appendicitis (combination of treatment failure, complication requiring general anesthesia or recurrent 
appendicitis) 
 
We will set a non-inferiority margin of 20% for this study. Thus the primary null hypothesis for this 
trial is H0:µnon-op - µop > 0.2 (inferiority), where µnon-op and µop are the probabilities of the primary 
outcome occurring in the non-operative arm and the appendectomy arm, respectively. The alternative 
hypothesis on which the sample size is based on is H1:µnon-op - µop ≤ 0.13 (i.e. 20%-7%). The power 
for this trial will be set to 90%; therefore to have a 90% probability of rejecting H0 when H1 is true, 
using a one-sided, 0.05 level test, we will require a total of 880 children (2 equal groups of 440). To 
allow for a combined 10% drop out and loss to follow-up, we intend to recruit 978 (i.e. 880/0.9) 
children in total. Based on the characteristics of participating centres we estimate recruitment will take 
place over a period of 24-30 months. 
 
Analysis 
Final analysis will be performed after the final patient has completed 1 year follow-up after 
randomization. Baseline variables will be compared between groups using the appropriate descriptive 
statistics. The primary outcome will be analysed by testing, at the 5% level (one-sided), the null 
hypotheses H0:µnon-op - µop > 0.2 (inferiority) versus the alternative hypothesis HA1:µnon-op - µop  ≤  0.13 
(non-inferiority), where µnon-op and µop are the probabilities of the primary outcome occurring in the 
non-operative arm and the operative arm, respectively. To facilitate this test of hypothesis, the 90% 
confidence interval for µnon-op - µop will be constructed. If the upper-bound of the confidence interval 
is less than 0.2, the null hypothesis will be rejected and the non-operative arm will be declared non-
inferior. Time to discharge will be compared between treatment arms using a Mann-Whitney U-test to 
account for right skewing from most patients spending a short time in the hospital with few and 
widely variable protracted stays. The incidence of complications will be compared between treatment 
arms using a two-sided Fisher exact test. The number of hospital admissions will be compared 
between treatment arms using a Poisson model and the total duration of hospital admissions in the 
first year following randomization will be compared between treatment arms using a Mann-Whitney 
U-test. All outcomes will be analysed on an intention-to-treat basis. We will also analyse outcomes by 
the stratification criteria (gender, duration of symptoms, centre). As an exploratory analysis in the 
subset of patients for whom the presence/absence of faecolith is known, an analysis of the primary 
outcome similar to the one described above will be performed with the presence/absence of 
appendicolith as a covariate. 
 
To ascertain the efficacy of treatment in the non-operative treatment groups, we will perform an 
interim analysis for the first half of the planned sample size. It will not be possible to use the primary 
outcome as defined for this interim analysis as data contributing to the primary outcome will not 
become measurable until 1 year following randomization. With a planned 1-year recruitment period to 
recruit ~50% of patients and with a 1-year follow-up, the time point at which this interim analysis 
would be performed would unavoidably occur near the end of our planned recruitment period (i.e. ~24 
months). We will therefore perform an interim analysis based on a modified primary outcome with a 
shorter (3 month following randomization) follow-up period. This analysis will be based on all 
elements of the primary outcome but with shorter follow-up. At the interim analysis we will test at the 
0.01 level (one-sided) the hypothesis HI0: µnon-op - µop ≤ 0.13 (non-inferiority) versus the alternative 
hypothesis HI1: µnon-op - µop > 0.13 (inferiority), where µnon-op and µop are the probabilities of the three-
month primary endpoint occurring in the non-operative arm and the operative arm, respectively. If the 
hypothesis HI0 is rejected in favour of HI1, patient recruitment will be stopped and the non-operative 
arm declared inferior. No adjustment for the final analysis will be required since the interim and final 
analyses test different hypotheses. The interim analysis will be performed blind to the investigators to 
the effect of bias influencing subsequent patient treatment. 
 
The objective of the economic evaluation is to measure the incremental costs of non-operative 
management versus surgical treatment for acute non-perforated appendicitis per treatment failure 
averted from societal and health care system perspectives. The design will be a cost-effectiveness 
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analysis (CEA) that weighs the direct and indirect health care costs in both treatment arms against the 
primary measure of effectiveness - treatment failures. The study will capture all costs and health 
consequences over a one-year period following randomization. Variables listed as secondary 
outcomes in the proposal (frequency and duration of hospital admissions, surgical interventions, 
treatment for adverse events and complications) will be included as cost items in the analysis. These 
analyses will be country-specific to reflect pricing differences. Only direct and indirect costs and 
resource use that can be attributed to the management of acute appendicitis and related complications 
will be included. Costs will be aggregated into major categories (intervention, direct health care, 
direct and indirect patient costs), and the mean cost per child will be calculated for each treatment 
group.  
 
The effect of uncertainty will be tested through extensive sensitivity analysis. Uncertain parameters 
may include the rate of treatment failures, hospital admission length of stay and cost, and the unit 
price for costly procedures. The probabilistic sensitivity analysis will also be used to undertake a net 
monetary benefit calculation. 
 
Trial oversight and safety monitoring 
A Trial Steering Committee (TSC) will be convened to ensure that the trial is conducted to rigorous 
scientific, clinical and ethical standards. A Data Safety and Monitoring Committee (DSMC) will be 
convened that is independent of both the trial management group and those providing therapy. Terms 
of reference and a Charter will be developed, based on the DAMOCLES (DAta Monitoring 
Committees: Lessons, Ethics, Statistics) Study Group 23 and StaR Child health Standard for Research 
with Children 24 25, and agreed at an initial meeting at the beginning of the trial prior to the onset of 
recruitment. Adverse events will be continuously monitored within each centre and reported to the 
trial co-ordinating centre. If any serious or unexpected adverse event occurs it will be reported to the 
chair of the DSMC chair within 72 hours. A summary of adverse events will be reviewed at interim 
analysis and the DSMC will make a recommendation to the Trial Steering Committee (TSC) 
regarding continuation of the trial on safety grounds. 
Ethical considerations 
This study will be conducted in accordance with the principles of the Declaration of Helsinki and 
‘good clinical practice’ guidelines as defined by each trial site. Written informed consent will be 
obtained from all participants prior to randomization. Our pilot RCT and ongoing observational 
cohort studies suggest that non-operative treatment of uncomplicated appendicitis in children is safe 16 
26 27. The protocol has already received ethical approval in 6 of the participating centres. 
 
Discussion 
The APPY trial is based on the hypothesis that a high proportion of children with acute uncomplicated 
appendicitis can be successfully treated with broad-spectrum antibiotics thereby avoiding a large 
number of appendectomies. Previous studies of the use of antibiotics in both adults and children suggest 
that this is likely to be achievable. Whether non-operative treatment with antibiotics is as effective a 
treatment as appendectomy for this patient population, however, is a more complex question. We 
believe this is determined by other factors in addition to the success of the initial treatment. For this 
reason these parameters are included in our composite primary outcome and include incidence of 
complications in each group, incidence of negative appendectomy and recurrence of appendicitis. 
 
The selection of an appropriate and relevant primary outcome is important for any RCT. Selection of a 
primary endpoint which does not reflect the interests of the stakeholder groups involved in treatment 
selection for a given pathology is likely to lessen the relevance and impact of a trial. For this reason it 
has been proposed that Core Outcome Sets (COS) be developed. A COS is an established set of 
outcomes to be measured when evaluating treatment efficacy for a given condition and is usually arrived 
at by consensus amongst multiple stakeholder groups (e.g. clinicians, researchers, patients/parents, 
treatment commissioners). The adoption of a COS will likely ensure that outcomes reported are relevant 
and of importance to multiple stakeholder groups. Further, use of a COS will ensure that a standardised 
set of outcome measures is reported as a minimum for a given pathology thereby minimising the 
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heterogeneity in outcome reporting between studies. This will improve comparability between studies 
in quantitative data synthesis such as meta-analysis. Although efforts are underway to develop a COS 
for children with acute appendicitis 28, a COS does not exist at present. 
 
We have therefore selected a primary endpoint that we believe reflects the important aspects of 
treatment outcomes on which we as clinicians and researchers would base future treatment decisions 
for children with acute appendicitis. We have also been influenced by our discussions with our patients 
and their parents. Negative appendectomy is a frequent finding in most series of paediatric 
appendectomy and suggests that an unnecessary operation has been performed. A benefit of a non-
operative approach would be to avoid an unnecessary operation, albeit it at the cost of an unnecessary 
course of antibiotics. Complications of treatment are important when evaluating treatment efficacy. Our 
definition of complications has been designed to capture the failure of non-operative treatment as well 
as complications requiring general anaesthesia in either treatment group. General anaesthesia has been 
selected as a marker of the impact of the complication on the patient as per the widely used Clavien-
Dindo classification of surgical complications 22. Finally we have included recurrent appendicitis in our 
primary outcome. If the rate of recurrent appendicitis is high then the benefit of initial non-operative 
treatment is less. If an appendectomy is going to be required for recurrence then it may as well be 
performed at first presentation. As the primary motivation of non-operative treatment is to avoid an 
operation and general anaesthesia, we felt the components of the primary outcome should reflect this 
motivation and therefore be centred around general anaesthesia. Other complications not-requiring a 
general anaesthetic are extremely important to capture and are therefore included as a specific secondary 
outcome measure (i.e. complications not resulting in general anaesthesia classified according to the 
Clavien-Dindo scale). In addition the resource utilization aspect of these complications will be captured 
in the economic analysis. 
 
Currently diagnosis of acute appendicitis in participating centres results in a false positive rate of 4-6%, 
i.e. a 4-6% rate of negative appendectomy. Thus, some of those recovering from non-operative 
management of suspected acute appendicitis will likely be those false positives who did not have acute 
appendicitis in the first place, in addition to children with antibiotic-responsive acute appendicitis. As 
no pathological specimen is taken from those who recover effectively with non-operative treatment, we 
will not accurately know how many of these patients actually had appendicitis. It would not be ethically 
acceptable to undertake additional tests (e.g. computed tomography, laparoscopic biopsy) in order to 
determine whether these patients actually had appendicitis or not, but we believe that not operating on 
patients who do not have acute appendicitis is one of the potential benefits of non-operative 
management. 
 
An additional challenge is how to define efficacy in a RCT such as this. We have selected a non-
inferiority design since we wish to evaluate whether non-operative treatment is as effective, but not 
necessarily more effective, than the current standard of care (appendectomy). If non-operative treatment 
is as effective as appendectomy, the potential benefits include avoiding surgery and its inherent risks, 
avoiding general anaesthesia, a potential shorter recovery time, and reduced costs to the institution and 
the health care system. Similar trials in adults have used comparative designs. To determine the efficacy 
of non-operative treatment we will compare how inferior it is to appendectomy. The non-inferiority 
margin we are willing to accept will in part determine its efficacy. 
 
There is no accepted guidance regarding the magnitude of a non-inferiority margin for surgical trials. 
A previous similar study in adults 8 comparing surgery with non-operative treatment for acute 
appendicitis in adults used a non-inferiority margin of 10%, which has been criticised by some as being 
too narrow 29. A Cochrane review of appendectomy versus antibiotic treatment for acute appendicitis  3 
proposed a non-inferiority margin of 20% on the basis that non-operative treatment may be marginally 
less effective but be more patient friendly, thereby justifying a wider non-inferiority margin. We believe 
that avoidance of an abdominal operation and general anaesthesia provides enough benefit to the patient 
to justify this wider non-inferiority margin of 20%. A recently reported RCT in adults used a 24% non-
inferiority margin 9. It was felt by the trial investigators that setting a non-inferiority margin of more 
than 20% would be too wide, as negative appendectomy is included in the appendectomy group so that 
a wider margin would be too ‘generous’ to the non-operative group. In addition, even if the treatment 
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failure rate of non-operative treatment falls outside the non-inferiority limits, the trial will usefully 
inform the discussion between surgeons, patients and their parents, and non-operative treatment might 
still be regarded as a viable treatment option, albeit with a lower success rate.  
 
In the protocol, each centre is allowed to maintain current antibiotic protocols. This is in keeping with 
current concepts of local antibiotic stewardship and the fact that no single antibiotic regime for acute 
appendicitis is of proven efficacy over another. It is not the aim of the study to determine an optimal 
antibiotic therapy for acute appendicitis, but to effectively answer the question ‘Is non-operative 
management of acute appendicitis in children, using current local antibiotic policies, non-inferior to 
operative management’. It is possible that some individual regimens may be more effective than others, 
and data from the trial might be used as hypothesis-generating in order to design future studies to 
optimise antibiotic therapy. However, the trial is not powered to examine differences in antibiotic 
regimens and as a result of this, comparison of antibiotic regimens is not listed as a specific secondary 
endpoint. All centres will use a broad spectrum approach to overcome the limitations of a narrow 
spectrum antibiotic regime encountered by others 8 29 
 
We have specifically designed the APPY trial as a randomised controlled trial. We believe the RCT 
design is the most appropriate methodology to determine the comparative effectiveness of non-
operative treatment compared to appendectomy 30. We are aware of the use of a ‘parent/patient choice’ 
design utilised by other studies in both adults 31 and children 32. Although parental choice may ultimately 
prove to be important in the treatment of acute appendicitis in children, we believe this parental choice 
must be informed by high-quality evidence of the treatment failure rates of each approach in identical 
groups of patients. A parent preference design runs the risk of introducing bias between the treatment 
arms, indeed such a bias is almost implicit in the act of choice itself. Despite the challenges and 
limitations of a RCT, we therefore strongly believe that a randomized study introduces less bias and is 
superior to a parent preference-based study. The 40% recruitment rate from the pilot randomised 
controlled trial suggests that many children and parents are uncomfortable with the possibility of not 
having the appendix removed, and whilst we believe that even if the current large scale trial indicates 
non-inferiority of non-operative management, there will likely always be some children and their 
parents who will opt to have an operation. The recruitment rate from the current trial will also be and 
important metric to gauge potential generalizability on a wider scale. 
An additional challenge for many surgical trials in particular is to ensure generalizability of trial findings 
after completion. This trial will therefore be a pragmatic trial in which we will aim to use existing 
treatment pathways in use at participating centres yet with adequate standardisation across treatment 
groups to allow meaningful comparison. Our entry criteria will therefore be based on a clinical and/or 
radiological diagnosis of acute, uncomplicated (non-perforated) appendicitis. There will be no strict 
requirement for the diagnosis to be based on US or CT scan. The patients who will be eligible for 
recruitment to this trial are the very ones who are currently being treated with appendectomy for acute 
appendicitis no matter how the diagnosis is currently made. Children with a fecolith on imaging or 
raised white cell count or CRP will all be eligible for inclusion. Finally the laparoscopic approach will 
be the standard for children in the appendectomy arm since this is the approach in current standard use 
at participating institutions. 
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